Profile | GDS4284 / 235683_at |
Title | Chronic lymphocytic leukemia response to antisense Bcl-2 inhibitor SPC2996: peripheral blood |
Organism | Homo sapiens |
Sample | Title | Value | Rank |
---|---|---|---|
GSM687644 | Patient 401 control | 1150.65 | 76 |
GSM687648 | Patient 402 control | 2248.77 | 85 |
GSM687653 | Patient 403 control | 844.645 | 72 |
GSM687658 | Patient 404 control | 1125.04 | 76 |
GSM687663 | Patient 411 control | 4310.61 | 92 |
GSM687668 | Patient 422 control | 2329.08 | 86 |
GSM687673 | Patient 424 control | 7355.95 | 96 |
GSM687678 | Patient 425 control | 2143.11 | 85 |
GSM687683 | Patient 427 control | 4793.88 | 93 |
GSM687688 | Patient 428 control | 900.088 | 72 |
GSM687695 | Patient 441 control | 16477.2 | 98 |
GSM687699 | Patient 443 control | 2035.92 | 84 |
GSM687704 | Patient 444 control | 1571 | 81 |
GSM687707 | Patient 448 control | 1509.25 | 80 |
GSM687712 | Patient 449 control | 1600.7 | 81 |
GSM687719 | Patient 450 control | 5499.24 | 94 |
GSM687724 | Patient 451 control | 6293.79 | 95 |
GSM687728 | Patient 452 control | 2696.52 | 88 |
GSM687646 | Patient 401 treated 24h | 695.051 | 68 |
GSM687649 | Patient 402 treated 24h | 2187.08 | 85 |
GSM687665 | Patient 411 treated 24h | 4746.4 | 93 |
GSM687651 | Patient 402 treated 4 weeks | 2688.15 | 88 |
GSM687667 | Patient 411 treated 4 weeks | 2213.15 | 85 |
GSM687670 | Patient 422 treated 24h | 2586.2 | 87 |
GSM687671 | Patient 422 treated 4 weeks | 2685.04 | 87 |
GSM687654 | Patient 403 treated 24h | 1181.27 | 77 |
GSM687675 | Patient 424 treated 24h | 8595.02 | 96 |
GSM687685 | Patient 427 treated 24h | 4068.33 | 92 |
GSM687656 | Patient 403 treated 4 weeks | 1328.09 | 78 |
GSM687677 | Patient 424 treated 4 weeks | 3570.62 | 90 |
GSM687687 | Patient 427 treated 4 weeks | 1033.9 | 74 |
GSM687692 | Patient 428 treated 4h | 1181.04 | 76 |
GSM687716 | Patient 449 treated 4h | 576.79 | 66 |
GSM687722 | Patient 450 treated 4h | 5997.41 | 95 |
GSM687680 | Patient 425 treated 24h | 2884.88 | 88 |
GSM687690 | Patient 428 treated 24h | 1389.35 | 79 |
GSM687700 | Patient 443 treated 24h | 6889.27 | 96 |
GSM687705 | Patient 444 treated 24h | 1823.43 | 83 |
GSM687714 | Patient 449 treated 24h | 1824.66 | 83 |
GSM687721 | Patient 450 treated 24h | 10845.9 | 97 |
GSM687682 | Patient 425 treated 4 weeks | 2118.51 | 85 |
GSM687694 | Patient 428 treated 4 weeks | 1791.06 | 82 |
GSM687702 | Patient 443 treated 4 weeks | 2190.64 | 85 |
GSM687718 | Patient 449 treated 4 weeks | 711.244 | 69 |
GSM687723 | Patient 450 treated 4 weeks | 3632.33 | 91 |
GSM687661 | Patient 404 treated 4h | 1491.06 | 80 |
GSM687710 | Patient 448 treated 4h | 2610.42 | 87 |
GSM687726 | Patient 451 treated 4h | 6284.06 | 95 |
GSM687730 | Patient 452 treated 4h | 5498.06 | 95 |
GSM687660 | Patient 404 treated 24h | 6940.5 | 95 |
GSM687697 | Patient 441 treated 24h | 6985.2 | 95 |
GSM687709 | Patient 448 treated 24h | 2352.14 | 86 |
GSM687725 | Patient 451 treated 24h | 7436.56 | 96 |
GSM687729 | Patient 452 treated 24h | 9163.88 | 96 |
GSM687727 | Patient 451 treated 4 weeks | 4544 | 93 |
GSM687731 | Patient 452 treated 4 weeks | 1813.8 | 83 |